2003
DOI: 10.1016/s0006-291x(03)01529-8
|View full text |Cite
|
Sign up to set email alerts
|

The role of protein phosphorylation in α2,6(N)-sialyltransferase activity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
5
0

Year Published

2009
2009
2020
2020

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(6 citation statements)
references
References 18 publications
1
5
0
Order By: Relevance
“…Therefore, activation of PKC pathway can promote both UT-A1 and UT-A3 sialylation. This is consistent with a study by Breen et al showing that stimulation of PKC resulted in an increase in ST6GalI catalytic activity (5). Ma et al reported the presence of phosphorylated serine and threonine sites on α2, 6-sialyltransferase (12), suggesting a functional involvement of ST6GalI-mediated sialylation by PKC activation.…”
Section: Discussionsupporting
confidence: 93%
See 1 more Smart Citation
“…Therefore, activation of PKC pathway can promote both UT-A1 and UT-A3 sialylation. This is consistent with a study by Breen et al showing that stimulation of PKC resulted in an increase in ST6GalI catalytic activity (5). Ma et al reported the presence of phosphorylated serine and threonine sites on α2, 6-sialyltransferase (12), suggesting a functional involvement of ST6GalI-mediated sialylation by PKC activation.…”
Section: Discussionsupporting
confidence: 93%
“…Lipid raft fractions (2-5) were collected for lectin pull-down assay and followed by Western blot with antibodies to UT-A1 NH 2 -terminus. A representative blot was shown from >3 different experiments.…”
Section: Figurementioning
confidence: 99%
“…For example, treatment of NRK cells with activators of protein kinase A alters vesicular stomatitis virus G protein glycosylation in infected cells (Muniz et al, 1996;Muniz et al, 1997). Furthermore, protein kinase C activity modulates sialylation of glycosphingolipids in NG108-15 and of glycoproteins in SH-SY5Y, as well as polysialylation of NCAM in neuro-2A and PC-12 cells (Bieberich et al, 1998;Breen and Georgopoulou, 2003;Gallagher et al, 2000). However, the functional consequences of these pharmacological effects have not been validated in vivo, nor have molecular or cellular mechanisms underlying altered glycosylation been identified.…”
Section: Tissue-specific Protein Glycosylation Requires Coordinated Tmentioning
confidence: 99%
“…The proposed involvement of PKC in the regulation of PST-mediated NCAM polysialylation state stems from the observation that phorbol-12-myristate-13-acetate, which activates diacylglycerol-dependent PKC isoforms, induces a dose-dependent decrease in NCAM PSA expression in neuro-2A neuroblastoma cells and staurosporine, a pan-specific PKC inhibitor, increases NCAM polysialylation state [26] Moreover, immunoblotting procedures have demonstrated reduced PKC expression to be associated with the enhanced polysialylation of NCAM in vitro and, using a polyclonal antibody directed against a conserved 11-amino acid sequence in E. coli polysialyltransferase, hippocampal PKC has been found to form complexes with PST that increase as animals age [27] and NCAM PSA expression decreases in an exponential manner [28]. The PST associated with these complexes has also been observed to be phosphorylated on serine residues [27], a mechanism known to be associated with the inhibition of other sialyltransferases [29], [30], [31] and [32]. Phosphorylated tyrosine residues on PST are also found in PST:PKC immunocomplexes [27] and this may play a crucial role in regulating PKC expression as phosphorylation of conserved tyrosine residues in the hinged bilobal structure, typical of the PKC family of isozymes, confers a specific post-translational control on the rate of proteolytic cleavage [33] and [34].…”
Section: Introductionmentioning
confidence: 99%